NextCure, Inc. (NXTC) Social Stream
NEXTCURE INC (NXTC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NXTC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-14 | 6 | $21 | $10 | $15 | $1.19 | 1160.5% |
| 2021-11-15 | 6 | $21 | $11 | $15.5 | $1.19 | 1202.52% |
| 2021-12-03 | 6 | $21 | $7 | $14.5 | $1.19 | 1118.49% |
| 2021-12-13 | 5 | $21 | $7 | $15.2 | $1.19 | 1177.31% |
| 2022-01-11 | 6 | $21 | $7 | $15.5 | $1.19 | 1202.52% |
| 2022-02-04 | 7 | $21 | $7 | $14.5 | $1.19 | 1118.49% |
| 2022-03-04 | 6 | $21 | $7 | $14.714 | $1.19 | 1136.47% |
| 2022-03-13 | 7 | $21 | $7 | $14.714 | $1.19 | 1136.47% |
| 2022-05-09 | 7 | $21 | $6 | $14.142 | $1.19 | 1088.4% |
| 2022-05-23 | 7 | $19 | $6 | $13 | $1.19 | 992.44% |
| 2022-08-13 | 6 | $19 | $6 | $12.333 | $1.19 | 936.39% |
| 2022-09-17 | 6 | $16 | $6 | $11.666 | $1.19 | 880.34% |
| 2022-11-04 | 5 | $16 | $5 | $7.8 | $1.19 | 555.46% |
| 2022-12-02 | 5 | $6 | $1 | $4.25 | $1.19 | 257.14% |
| 2023-08-06 | 5 | $6 | $1 | $4.333 | $1.19 | 264.12% |
| 2023-11-03 | 5 | $7 | $1 | $5 | $1.19 | 320.17% |
| 2023-12-14 | 4 | $6 | $3 | $4.666 | $1.19 | 292.1% |
The Trend in the Analyst Price Target
Over the past 43 months, NXTC's average price target has gone down $60.67.
NXTC reports an average of 229.15% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-06 | 4 | 6 | 1 | 4.333 | 1.82 | 138.08% |
| 2023-08-06 | 5 | 6 | 1 | 4.333 | 1.70 | 154.88% |
| 2023-08-06 | 4 | 6 | 1 | 4.333 | 1.70 | 154.88% |
| 2023-08-31 | 5 | 7 | 1 | 5.000 | 1.46 | 242.47% |
| 2023-11-03 | 4 | 7 | 6 | 6.333 | 1.18 | 436.69% |
NXTC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.75 | 2 | 1 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 39 weeks, NXTC's average broker recommendation rating improved by 0.75.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- NEXTCURE INC's upside potential (average analyst target price relative to current price) is greater than 2184.43% of all US stocks.
- In terms of how NEXTCURE INC fares relative to all US stocks, note that its average analyst price target is higher than 274.25% of that group.
- To contextualize these metrics, consider that out of all US stocks, NEXTCURE INC's variance in analysts' estimates is lower than -1732.42% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, NEXTCURE INC's number of analysts covering the stock is greater than 692.12% of them.
Stocks similar to NEXTCURE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MIST, CYCN, and APM.
View All Top Stocks by Price Target
What is the outlook for NXTC? Use POWR Ratings for clearer insight into price direction.